Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

Clinical trial NCT06263153 · RECRUITING

Trial details

NCT number: NCT06263153
Sponsor: Yuanquan Yang
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Urothelial Carcinoma Muscle Invasive Bladder Carcinoma Stage II Bladder Cancer AJCC v8 Stage IIIA Bladder Cancer AJCC v8

Start date: 2024-12-30
Primary completion: 2026-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.